JPH09224607A - Diet assisting food - Google Patents

Diet assisting food

Info

Publication number
JPH09224607A
JPH09224607A JP8060177A JP6017796A JPH09224607A JP H09224607 A JPH09224607 A JP H09224607A JP 8060177 A JP8060177 A JP 8060177A JP 6017796 A JP6017796 A JP 6017796A JP H09224607 A JPH09224607 A JP H09224607A
Authority
JP
Japan
Prior art keywords
extract
ethanol
garcinia cambogia
diet
raw material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8060177A
Other languages
Japanese (ja)
Inventor
Junichi Kasai
潤一 葛西
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
L S CORP KK
Soken Co Ltd
Original Assignee
L S CORP KK
Soken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L S CORP KK, Soken Co Ltd filed Critical L S CORP KK
Priority to JP8060177A priority Critical patent/JPH09224607A/en
Publication of JPH09224607A publication Critical patent/JPH09224607A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a diet assisting food having excellent weight-reducing effect and acceptable taste and useful for the amelioration of obesity by treating ethanol with a magnetic field, adding the treated ethanol to a raw material composed mainly of Garcinia cambogia extract, etc., and granulating the mixture in wet state. SOLUTION: Ethanol subjected to a magnetic field treatment is added to a raw material containing (A) Garcinia cambogia extract and Gymnema sylvestre extract (at a ratio of preferably 1/5 to 5/1) as main components and (B) preferably 6-30wt.% each (based on the sum of the main components) of salmon soft roe extract, RNA concentrated yeast extract and parsley powder as subsidiary components and the obtained mixture is granulated in wet state.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明はガルシニア・カンボ
ジアエキスとギムネマ・シルベスタエキスを主成分とす
る肥満の改善促進に有用なダイエット補助食品に関す
る。
TECHNICAL FIELD The present invention relates to a diet supplement containing garcinia cambogia extract and Gymnema sylvestre extract as main components and useful for promoting improvement of obesity.

【0002】[0002]

【従来の技術】肥満を改善する基本は食物から摂取する
カロリーを減らすと共に、運動などによるエネルギー消
費を増やすことにある。カロリー減少を助けるものとし
て従来から種々の低カロリーの食事代替品が開発され、
ダイエット食品として市販されている。しかし一般のダ
イエット食品は嗜好性などから摂取を長続きさせること
が難しく、期待される肥満改善までに至らない場合が多
い。そこで、食前に少量飲むだけでカロリー吸収を抑制
し、平均的な量の食事を摂取しても肥満を改善すること
ができるようなダイエット補助食品が開発されている。
2. Description of the Related Art The basis for improving obesity is to reduce calories ingested from food and to increase energy consumption due to exercise and the like. Various low-calorie meal replacements have been developed to help reduce calories.
It is marketed as a diet food. However, general dietary foods are difficult to continue ingesting due to their palatability and the like, and in many cases do not reach the expected improvement in obesity. Therefore, diet supplements have been developed that suppress caloric absorption by drinking a small amount before meals and can improve obesity even if an average amount of meal is consumed.

【0003】このようなダイエット補助食品の主成分と
して従来から知られているものにギムネマ・シルベスタ
エキスがある。このギムネマ・シルベスタエキスは植物
のギムネマ葉から抽出されるものであるが、経口的に摂
取されたときに含有するギムネマ酸が単糖類の腸管吸収
を抑制するという作用がある。ギムネマ葉からギムネマ
・シルベスタエキスを取得する方法としては、例えば乾
燥ギムネマ葉を含水エタノールで抽出した後、固液分離
して減圧濃縮する方法(特開昭62−246591号公
報)、同様に抽出した液を逆浸透膜で濃縮する方法(特
開平2−215727号公報)等が知られている。そし
てこのようにして得られたギムネマ・シルベスタエキス
にプルランを添加した低カロリー飲食物も提案されてい
る。(特公平3−8188号公報)
Gymnema sylvestre extract has been known as a main component of such diet supplements. This Gymnema sylvestre extract is extracted from Gymnema leaves of plants, and Gymnema acid contained when taken orally has the action of suppressing intestinal absorption of monosaccharides. As a method for obtaining Gymnema sylvestre extract from Gymnema leaves, for example, a method of extracting dried Gymnema leaves with hydrous ethanol, followed by solid-liquid separation and concentration under reduced pressure (JP-A-62-246591), the same extraction is performed. A method of concentrating a liquid with a reverse osmosis membrane (Japanese Patent Laid-Open No. 2-215727) and the like are known. Further, a low-calorie food or drink obtained by adding pullulan to the Gymnema sylvestre extract thus obtained is also proposed. (Japanese Patent Publication No. 3-8188)

【0004】また、ギムネマ・シルベスタエキスに類似
するものとして、ガルシニア・カンボジアエキスが知ら
れている。これはインド原産のガルシニア・カンボジア
という植物の果皮から抽出され、ヒドロキシクエン酸
(HCA)を含有している。HCAは経口的に摂取され
たとき、肝臓において余剰糖質から脂肪の合成されるこ
とを抑制する作用があり、さらに体脂肪の分解促進効果
や食欲抑制効果を有しているとされている。さらにギム
ネマ・シルベスタエキスとガルシニア・カンボジアエキ
スを併用したダイエット補助食品も知られており、上記
のような各成分の効果を合わせ持つものとして期待され
ている。
Garcinia cambogia extract is known to be similar to Gymnema sylvestre extract. It is extracted from the skin of a plant called Garcinia cambogia, which is native to India and contains hydroxycitric acid (HCA). When taken orally, HCA has an action of suppressing the synthesis of fat from excess sugar in the liver, and is further said to have a body fat decomposition promoting effect and an appetite suppressing effect. Further, a diet supplement containing a combination of Gymnema sylvestre extract and Garcinia cambogia extract is also known, and is expected to have the effects of each of the above components.

【0005】[0005]

【発明が解決しようとする課題】しかし本発明者は上記
のギムネマ・シルベスタエキスとガルシニア・カンボジ
アエキスを併用したダイエット補助食品による肥満改善
効果をテストしたが、予想されたほどの結果は得られな
かった。その原因は明確ではないが、肥満の原因はカロ
リー摂取量とエネルギー消費量のバランスの他に、基礎
代謝、新陳代謝、体内水分量、さらには心理的影響など
も関係し、それほど単純ではないということに原因があ
ると推定している。そこで本発明は、ギムネマ・シルベ
スタエキスとガルシニア・カンボジアエキスを併用した
ダイエット補助食品を、より肥満の改善効果の高いもの
に改良することを課題とするものである。
However, the present inventor tested the effect of improving obesity by the diet supplement containing the above-mentioned Gymnema sylvestre extract and Garcinia cambogia extract, but the result was not as expected. It was The cause is not clear, but the cause of obesity is not so simple because it is related to the balance of caloric intake and energy consumption, as well as basal metabolism, metabolism, body water content, and psychological effects. It is estimated that there is a cause. Therefore, it is an object of the present invention to improve a diet supplement containing a combination of Gymnema sylvestre extract and Garcinia cambogia extract to have a higher effect of improving obesity.

【0006】[0006]

【課題を解決するための手段】上記課題を解決した本発
明のダイエット補助食品は、ガルシニア・カンボジアエ
キスとギムネマ・シルベスタエキスを主成分とし、それ
に鮭白子エキス、RNA濃縮酵母エキスおよびパセリ粉
末を副成分とする原料を使用し、それに磁気処理をした
エタノール類を添加して湿式造粒することにより得られ
る。このようにして得られた本発明のダイエット補助食
品は、後述する実施例により実証されているように著し
い肥満改善効果があり、ギムネマ・シルベスタエキスと
ガルシニア・カンボジアエキスとを併用した従来のダイ
エット補助食品では十分な効果がなかった被試者に対し
ても、著しい肥満改善の効果が得られた。
Means for Solving the Problems The dietary supplement of the present invention, which has solved the above problems, contains Garcinia cambogia extract and Gymnema sylvestre extract as main components, and salmon shirako extract, RNA-enriched yeast extract and parsley powder as auxiliary substances. It can be obtained by using a raw material as a component, adding magnetically treated ethanol to it, and performing wet granulation. The dietary supplement of the present invention thus obtained has a significant obesity-improving effect as demonstrated by the examples described below, and a conventional dietary supplement using Gymnema sylvestre extract and Garcinia cambogia extract in combination. A significant effect of improving obesity was obtained even in subjects who did not have sufficient effects with food.

【0007】[0007]

【発明の実施の形態】次に、本発明のダイエット補助食
品の実施の形態を説明する。主成分であるギムネマ・シ
ルベスタエキスおよびガルシニア・カンボジアエキス
は、従来この分野で使用されているものと同様なものを
用いることができる。なお、これらのエキスは前記のよ
うに抽出濃縮されたものだけではなく、その前段階の葉
の粉末や濃縮前の抽出液も使用することができる。ギム
ネマ・シルベスタエキスおよびガルシニア・カンボジア
エキスの含有割合は、エキスの比率として1〜5:5〜
1好ましくは1:2程度とされる。鮭白子エキスは、鮭
の白子を水とエタノールで繰り返し洗浄し乾燥処理する
ことにより得られる。このエキスは鮭白子のデオキシリ
ボ核酸(DNA)に加えて精子蛋白質であるプロタミン
を含み、経口摂取することにより全身の新陳代謝を高
め、結果として基礎代謝を亢進させる効果がある。その
ため特に強制的な運動をしなくても基礎代謝の亢進によ
るエネルギー消費を増大させるので、肥満改善に大きく
寄与する。鮭白子エキスの添加量は、上記主成分の合計
重量に対して1〜50%、好ましくは6〜30%程度と
される。
BEST MODE FOR CARRYING OUT THE INVENTION Next, an embodiment of the dietary supplement of the present invention will be described. As Gymnema sylvestre extract and Garcinia cambogia extract, which are the main components, those similar to those conventionally used in this field can be used. It should be noted that these extracts are not limited to those extracted and concentrated as described above, but leaf powder of the previous stage or an extract before concentration can also be used. The content ratio of Gymnema sylvestre extract and Garcinia cambogia extract is 1 to 5: 5 as the ratio of extract.
1 is preferably about 1: 2. Salmon Shirako extract can be obtained by repeatedly washing salmon Shirako with water and ethanol and drying it. This extract contains protamine, which is a sperm protein in addition to salmon roe deoxyribonucleic acid (DNA), and has an effect of enhancing systemic metabolism by ingestion and consequently enhancing basal metabolism. Therefore, energy consumption due to the enhancement of basal metabolism is increased without particularly exercising, which greatly contributes to the improvement of obesity. The amount of salmon Shirako extract added is 1 to 50%, preferably 6 to 30%, based on the total weight of the main components.

【0008】RNA濃縮酵母エキスは、ビール酵母,食
用トルラ酵母等を原料に濃食塩水抽出とエタノール沈殿
処理をすることにより、リボ核酸(RNA)を50%以
上含有するように精製した酵母エキスである。この酵母
エキスは前記鮭白子エキスと同様に、経口摂取すること
により全身の新陳代謝を高める作用があり、特に強制的
な運動をしなくてもエネルギー消費を増大させるので、
肥満改善に大きく寄与する。RNA濃縮酵母エキスの添
加量は、上記主成分の合計重量に対して1〜50%、好
ましくは6〜30%程度とされる。パセリ粉末は香味野
菜であるパセリを乾燥し粉末化したもので、精油その他
の有効成分を含み、利尿作用や血液増加作用があること
が知られている。一般に肥満者が減量を行う際に細胞内
の水分が減らないと、体重減少が期待より緩慢になるの
で減量努力を途中で放棄することがあるが、パセリ粉末
の添加によりこのような減量意欲の低下を有効に防止で
きる。なおパセリ粉末の添加量は、上記主成分の合計重
量に対して1〜50%、好ましくは6〜30%程度とさ
れる。
The RNA-enriched yeast extract is a yeast extract that is purified so as to contain ribonucleic acid (RNA) by 50% or more by subjecting brewer's yeast, edible torula yeast, etc. as raw materials to concentrated saline extraction and ethanol precipitation. is there. This yeast extract, like the salmon Shirako extract, has the effect of enhancing the metabolism of the whole body by ingesting it, and since it increases energy consumption without particularly exercising,
It greatly contributes to the improvement of obesity. The amount of the RNA-enriched yeast extract added is 1 to 50%, preferably 6 to 30%, based on the total weight of the main components. Parsley powder is a powdered product of parsley, which is a flavored vegetable, and contains essential oils and other active ingredients, and is known to have a diuretic effect and a blood increasing effect. Generally, if the intracellular water is not reduced when the obese person loses weight, weight loss may be slower than expected, so weight loss efforts may be abandoned midway.However, the addition of parsley powder may reduce such weight loss motivation. The drop can be effectively prevented. The amount of parsley powder added is 1 to 50%, preferably 6 to 30%, based on the total weight of the main components.

【0009】次に、上記主原料とその他の副原料を使用
したダイエット補助食品の製造方法を説明する。図1は
本発明のダイエット補助食品を製造する工程を説明する
図であり、先ず主原料であるギムネマ・シルベスタエキ
スとガルシニア・カンボジアエキス、および副原料であ
る鮭白子エキス、RNA濃縮酵母エキスおよびパセリ粉
末を計量混合装置1においてそれぞれ所定量ずつ計量し
て攪拌混合する。次に、その混合物を湿式造粒装置2に
おいて純エタノールまたは可食性の変成エタノール等の
エタノール類と混合して湿式造粒する。次いでその造粒
体を乾燥装置4で乾燥し、さらに打錠装置5で錠剤化す
る。
Next, a method for producing a dietary supplement food using the above main raw material and other auxiliary raw materials will be described. FIG. 1 is a diagram illustrating a process for producing the dietary supplement of the present invention. First, Gymnema sylvestre extract and Garcinia cambogia extract, which are main ingredients, and salmon shirako extract, RNA-enriched yeast extract, and parsley, which are auxiliary ingredients. The powder is weighed by a predetermined amount in the weighing and mixing device 1 and mixed by stirring. Next, the mixture is mixed with ethanol such as pure ethanol or edible modified ethanol in the wet granulator 2 to perform wet granulation. Next, the granulated product is dried by the drying device 4 and further tableted by the tableting device 5.

【0010】エタノール類は湿式造粒装置2に供給する
前に、磁気処理装置3において磁気処理される。そして
このエタノール類は原料を湿式で混合造粒する際の助剤
としての機能を果たす。なお、食品製造プロセスにおけ
る処理水を磁気処理して味覚改善を試みることは従前よ
り行われているが、本発明のようなダイエット効果の増
強を主目的として補助食品の製造工程に使用された例は
ない。磁気処理装置3としては、例えば株式会社創健よ
り市販されている磁気カップ、商品名磁化水生命之水の
ような装置を使用することができる。この装置は被処理
液を静置収容する容器の周囲に磁気発生装置が設けら
れ、容器内の被処理液に所定時間磁束を印加して磁気処
理をするようになっている。
The ethanol is magnetically processed in the magnetic processing device 3 before being supplied to the wet granulation device 2. Then, the ethanols function as an auxiliary agent when the raw materials are wet-mixed and granulated. In addition, it has been performed for some time to attempt to improve the taste by magnetically treating the treated water in the food manufacturing process, but an example used in the manufacturing process of the supplement food mainly for the purpose of enhancing the diet effect as in the present invention. There is no. As the magnetic processing device 3, for example, a magnetic cup commercially available from Soken Co., Ltd., or a device having a trade name of magnetized water life life water can be used. In this apparatus, a magnetism generator is provided around a container that holds the liquid to be treated stationary, and a magnetic flux is applied to the liquid to be treated in the container for a predetermined time for magnetic treatment.

【0011】磁気処理をしないエタノール類を上記原料
に添加して湿式造粒、乾燥、打錠した実験では、錠剤中
の細菌数が原料中の細菌数より一桁程度減少していた
が、この磁気処理装置3を使用し270ガウスの磁場を
12時間印加して磁気処理したエタノール類を使用した
場合は、錠剤中の細菌数が原料中の細菌数より二桁減少
するという優れた結果が得られた。また、このような磁
気処理をしたエタノール類を使用した場合には、磁気処
理を行わない場合に対して、製品中に残存する原料臭お
よびエタノール臭が減少すると共に、製品の味も僅かに
向上するという結果が得られた。さらに、製品の変質や
変色も少なくなり、ビタミンの減少も磁気処理しない場
合より少ない等、製品の安定性にも寄与することが分か
った。
In an experiment in which ethanol without magnetic treatment was added to the above raw material, wet granulation, drying and tableting, the number of bacteria in the tablet was reduced by about an order of magnitude from the number of bacteria in the raw material. When the magnetic treatment apparatus 3 was used and magnetic treatment was performed by applying a magnetic field of 270 Gauss for 12 hours, the number of bacteria in the tablet was reduced by two orders of magnitude compared to the number of bacteria in the raw material. Was given. Also, when such magnetically treated ethanol is used, the raw material odor and ethanol odor remaining in the product are reduced and the taste of the product is slightly improved compared to the case without magnetic treatment. The result of doing is obtained. Furthermore, it has been found that the deterioration and discoloration of the product are reduced, and the reduction of vitamins is less than that without magnetic treatment, which contributes to the stability of the product.

【0012】[0012]

【実施例】次に、実施例により本発明をさらに具体的に
説明する。 (1)ダイエット補助食品の製造 図1の工程により、主原料としてガルシニア・カンボジ
アエキスとギムネマ・シルベスタエキス、副原料として
鮭白子エキス、RNA濃縮酵母エキスおよびパセリ粉末
を所定量計量・混合し、それらの原料100重量部あた
りに270ガウスの磁場で12時間磁気処理した純エタ
ノールを10重量部添加して湿式造粒し、次いで乾燥・
打錠して錠剤とした。錠剤は1粒当たり300mgであ
り、4粒当たりの成分は次のとおりであった。 ガルシニア・カンボジアエキス末(HCA50%含有) :500mg ギムネマ・シルベスタエキス(乾燥葉換算750mg) :250mg 鮭白子エキス(鮭白子DNA30%品) : 50mg トルラ酵母エキス(RNA50%品) : 50mg パセリ粉末 :120mg
Next, the present invention will be described more specifically with reference to examples. (1) Production of dietary supplements By the process shown in FIG. 1, a predetermined amount of Garcinia cambogia extract and Gymnema sylvesta extract as main ingredients, salmon shirako extract, RNA-enriched yeast extract and parsley powder as auxiliary ingredients were weighed and mixed. 10 parts by weight of pure ethanol magnetically treated with a magnetic field of 270 gauss for 12 hours was added to 100 parts by weight of the raw material of No. 1 to wet granulate, followed by drying
Tablets were made into tablets. The tablet was 300 mg per grain, and the components per 4 grains were as follows. Garcinia cambogia extract powder (containing 50% HCA): 500 mg Gymnema sylvestre extract (750 mg dry leaf equivalent): 250 mg Salmon Shiroko extract (30% salmon Shiroko DNA product): 50 mg Torula yeast extract (50% RNA product): 50 mg Parsley powder: 120 mg

【0013】造粒前の原料中の一般細菌数は1.2×1
4 個/g程度であったが、錠剤中の一般細菌数は30
0個/g程度に減少していた。なお、比較のため磁気処
理しない純エタノールを使用する以外は上記実施例と同
様にして実験をした結果では、錠剤中の一般細菌数は
1.8×103 個/g程度であった。また、臭い,味に
ついても磁気処理をした場合の方が温和であった。なお
追加実験によれば、エタノール類を磁気処理したとき、
そのエタノール類が単独で殺菌効果が高まるのではな
く、磁気処理したエタノールを、ガルシア・カンボジア
エキスとギムネマ・シルベスタエキスを主成分とし、鮭
白子エキス、RNA濃縮酵母エキスおよびパセリ粉末を
副成分とする原料に添加して湿式造粒することにより始
めて殺菌効果が高まることが分かった。その理由は明ら
かではないが、これら各成分のいずれか一以上に存在す
る殺菌作用を強く引き出す効果が磁気処理したエタノー
ルに存在するものと推測できる。
The number of general bacteria in the raw material before granulation is 1.2 × 1
It was about 0 4 / g, but the number of general bacteria in the tablet was 30
The number was reduced to about 0 / g. As a result of conducting an experiment in the same manner as in the above example except that pure ethanol which was not magnetically treated was used for comparison, the number of general bacteria in the tablet was about 1.8 × 10 3 cells / g. Also, the smell and taste were milder when the magnetic treatment was performed. According to additional experiments, when ethanol was magnetically treated,
The ethanol does not enhance the bactericidal effect by itself, but the magnetically treated ethanol contains Garcia-Cambodia extract and Gymnema sylvesta extract as the main components, and salmon Shirako extract, RNA-enriched yeast extract and parsley powder as the auxiliary components. It was found that the bactericidal effect was enhanced only by adding it to the raw material and performing wet granulation. The reason for this is not clear, but it can be presumed that the magnetically treated ethanol has the effect of strongly eliciting the bactericidal action which is present in any one or more of these components.

【0014】(2)臨床例(比較例) 先ず、比較のために上記のような副原料を使用せず、主
原料であるガルシニア・カンボジアエキスとギムネマ・
シルベスタエキスのみを使用し、さらに磁気処理しない
純エタノールを使用して製造したダイエット食品により
臨床試験を行った。製造した錠剤は1粒当たり300m
gであり、4粒当たりの成分はガルシニア・カンボジア
エキス末(HCA50%含有)が500mg、ギムネマ
・シルベスタエキス(乾燥葉の3倍濃度エキス)が25
0mgであった。この錠剤を被験者に3食前毎に4粒ず
つ摂取させ、2カ月後の体重減少効果を測定した。結果
は表1のように平均の体重減少は2カ月間で2.6Kg
であり、顕著な減量効果が得られた被験者もある一方
で、ほぼ無効であると判断された被験者も3割程度存在
した。
(2) Clinical Example (Comparative Example) First, for comparison, the above-mentioned auxiliary materials were not used, but Garcinia cambogia extract and Gymnema
A clinical test was conducted using a diet food produced using only sylvester extract and pure ethanol without magnetic treatment. Each tablet produced is 300m
The composition per 4 grains is 500 mg of Garcinia cambogia extract powder (containing 50% of HCA), and Gymnema sylvesta extract (three times the concentration of dried leaves) is 25 g.
0 mg. Subjects took 4 tablets of this tablet every 3 meals before measuring the weight loss effect after 2 months. As shown in Table 1, the average weight loss was 2.6 kg in 2 months.
Thus, while some subjects were able to obtain a remarkable weight-loss effect, about 30% of subjects were judged to be almost ineffective.

【0015】[0015]

【表1】 [Table 1]

【0016】(3)臨床例(実施例) 次に、前記のように製造した本発明のダイエット補助食
品を使用して上記比較例と同様な実験をした。なお、被
験者として上記比較例でほぼ無効と判断された5名を選
び、前の実験から1カ月経過してから実験を開始した。
被験者に3食前毎に4粒ずつ錠剤を摂取させ、45日後
の体重減少効果を測定した結果を表2に示す。これから
分かるように、比較例よりテスト期間が短かったにもか
かわらず極めて優れた減量効果が得られた。また、製品
の臭い味も温和になり、被験者の受容性も高まった。
(3) Clinical Example (Example) Next, the same experiment as in the above Comparative Example was conducted using the dietary supplement of the present invention produced as described above. In addition, 5 subjects who were judged to be almost ineffective in the above-mentioned comparative example were selected as subjects, and the experiment was started after one month passed from the previous experiment.
Table 2 shows the results of measuring the weight loss effect after 45 days by allowing the test subjects to ingest 4 tablets every 3 meals. As can be seen from this, an extremely excellent weight loss effect was obtained despite the shorter test period than the comparative example. In addition, the odor and taste of the product became mild, and the acceptability of the test subject was increased.

【0017】[0017]

【表2】 [Table 2]

【0018】[0018]

【発明の効果】以上のように本発明のダイエット補助食
品は、従来より減量効果が著しく高い上に製品中の一般
細菌数も極めて低いという優れた効果を奏し且つ、味覚
的な受容性も高まる。
INDUSTRIAL APPLICABILITY As described above, the dietary supplement of the present invention exerts an excellent effect that the weight-reducing effect is remarkably high and the number of general bacteria in the product is also extremely low, and the taste acceptability is also enhanced. .

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明のダイエット補助食品を製造する工程を
説明する図である。
FIG. 1 is a diagram illustrating a step of producing a dietary supplement according to the present invention.

【符号の説明】[Explanation of symbols]

1 計量・混合装置 2 湿式造粒装置 3 磁気処理装置 4 乾燥装置 5 打錠装置 1 Weighing / mixing device 2 Wet granulating device 3 Magnetic processing device 4 Drying device 5 Tableting device

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A23L 2/30 Z ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display area A23L 2/30 Z

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 ガルシニア・カンボジアエキスとギムネ
マ・シルベスタエキスを主成分とし、鮭白子エキス、R
NA濃縮酵母エキスおよびパセリ粉末を副成分とする原
料に磁気処理をしたエタノール類を添加して湿式造粒す
ることにより得られたダイエット補助食品。
1. Salmon Shirako extract, R, containing Garcinia cambogia extract and Gymnema sylvestre extract as main components.
A diet supplement obtained by wet-granulating by adding magnetically-treated ethanol to a raw material containing NA-enriched yeast extract and parsley powder as auxiliary components.
JP8060177A 1996-02-21 1996-02-21 Diet assisting food Pending JPH09224607A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8060177A JPH09224607A (en) 1996-02-21 1996-02-21 Diet assisting food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8060177A JPH09224607A (en) 1996-02-21 1996-02-21 Diet assisting food

Publications (1)

Publication Number Publication Date
JPH09224607A true JPH09224607A (en) 1997-09-02

Family

ID=13134621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8060177A Pending JPH09224607A (en) 1996-02-21 1996-02-21 Diet assisting food

Country Status (1)

Country Link
JP (1) JPH09224607A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010285425A (en) * 2009-05-12 2010-12-24 Fujifilm Corp Agent for regulating composition ratio of intestinal bacterial flora
JP4750213B1 (en) * 2010-05-21 2011-08-17 株式会社 ファイナルフューチャーインターナショナル Adiponectin production promoting composition
WO2013054525A1 (en) * 2011-10-12 2013-04-18 フォーデイズ株式会社 Glutathione-containing health drink
EP2484370A4 (en) * 2009-10-02 2014-02-26 Final Future International Inc Composition having lipolysis-promoting effect
JP2020100608A (en) * 2018-12-25 2020-07-02 株式会社日本電医研 Nutritional supplement, and medicine or food/drink containing the nutritional supplement

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010285425A (en) * 2009-05-12 2010-12-24 Fujifilm Corp Agent for regulating composition ratio of intestinal bacterial flora
EP2484370A4 (en) * 2009-10-02 2014-02-26 Final Future International Inc Composition having lipolysis-promoting effect
JP4750213B1 (en) * 2010-05-21 2011-08-17 株式会社 ファイナルフューチャーインターナショナル Adiponectin production promoting composition
WO2011145307A1 (en) * 2010-05-21 2011-11-24 株式会社 ファイナルフューチャーインターナショナル Adiponectin production accelerating composition
CN102892423A (en) * 2010-05-21 2013-01-23 最终未来国际股份有限公司 Adiponectin production accelerating composition
US8883138B2 (en) 2010-05-21 2014-11-11 Final Future International, Inc. Adiponectin production accelerating composition
WO2013054525A1 (en) * 2011-10-12 2013-04-18 フォーデイズ株式会社 Glutathione-containing health drink
CN103874431A (en) * 2011-10-12 2014-06-18 福蒂姿株式会社 Glutathione-containing health drink
JPWO2013054525A1 (en) * 2011-10-12 2015-03-30 フォーデイズ株式会社 Cysteine peptide-containing health drink
JP2020100608A (en) * 2018-12-25 2020-07-02 株式会社日本電医研 Nutritional supplement, and medicine or food/drink containing the nutritional supplement

Similar Documents

Publication Publication Date Title
JP3782122B2 (en) Metabolism promoter for oral intake and food containing the same
US20040013784A1 (en) Additive method of standardized drinks and potable water production
JP4231208B2 (en) Nutritional supplements derived from fermented milk for the prevention of osteoporosis
CN111902049A (en) Health beverage composition having excellent hangover alleviating effect and preventing liver damage due to alcohol
WO2009082883A1 (en) Antiobesity composition
JPH09224607A (en) Diet assisting food
CN114786502A (en) Muscle-building agent
CN108308621A (en) A kind of weight losing meal-replacing powder rich in rice oligopeptide
RU2283124C1 (en) Biologically active preparation based on marine vegetable raw
CN112715874A (en) Blueberry powder compound solid preparation for resisting fatigue and improving sexual dysfunction as well as preparation method and application thereof
JP3489095B2 (en) Health foods and beverages
RU2390271C1 (en) Preparation for increasing of organism adaptability to extreme conditions
JP2003189818A (en) Functional food containing powdery sea-squirt
JPS6062944A (en) Nutrient reducing tea
JPH1149690A (en) Composition for stimulating lipolysis
JP2003023970A (en) Method of production for collagen, chitin compound material obtained from fish scale and method of utilizing the same for food
JP2001019642A (en) Production of analeptic containing powdery natural pearl as main ingredient and its utilization
JP3713553B2 (en) Cerebrospinal neurotrophic agent containing arginine and RNA
JP2808281B2 (en) Protein foods and physiological supplements
RU2776298C1 (en) Biologically active food additives based on ascorbic acid and stevia extract
CN108991358A (en) A kind of auxiliary reducing blood lipid, it is hypoglycemic, alleviate gout health care food and production method
EP2618685A2 (en) Trivalent chromium and boron fortifying composition, a hydration supplement, and process for preparing the same
CN108096281A (en) A kind of strong blood body building composition
JP6003018B2 (en) Hepatoprotective agent, pharmaceutical composition, and composition for protecting cells, etc.
CN114980752A (en) Body fat reducing agent